Featured Research

from universities, journals, and other organizations

Flaw in Alzheimer's drug trial test, research suggests

Date:
December 16, 2012
Source:
University of Plymouth
Summary:
New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.

New research led by Plymouth University Peninsula Schools of Medicine and Dentistry suggests that the cognitive test used in Alzheimer's drug trials is flawed.

Related Articles


The current standard cognitive test for the disease is the ADAS Cog. The new research, published as two studies in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, investigates the role of the test and questions its effectiveness.

The studies show that the ADAS Cog is not subtle enough to properly track changes in the early stages of Alzheimer's. This is important because data from this key stage is required to show whether or not a new drug is working. The study also showed that the modern method of "Rasch analysis" confirmed the flaw.

In their first study, the researchers examined 675 measurements from people, aged 53 to 90, with mild Alzheimer's disease across five time points -- 0, six, 12, 18 and 24 months. In terms of final patient score the ADAS-cog seemed sound. But by breaking down all the data to component level, a different story emerged. A "ceiling effect" was exposed for eight out of the 11 parts of the ADAS-cog with many patients -- ranging from 32 to 83 per cent -- "passing" the section when in reality much greater variance between the patients almost certainly existed and needed scoring.

In the second study, the research team moved on to use the modern method of "Rasch analysis" to further test the data. This confirmed the flaw. The more sophisticated method of analysis also suggested a number of possible pathways to improvement including making parts of the ADAS-cog test more difficult as well as re-thinking the scoring structure.

As a consequence, the Plymouth-based research team is suggesting urgent changes to the ADAS Cog -- and is not ruling out the need for a new test.

The study was led by Professor Jeremy Hobart. He said: "It is impossible to say precisely the extent to which the ADAS Cog's flaws have undermined the numerous clinical trials in which it has been used. It has been used, unchanged, for many years and its apparent contribution to suboptimal trials has led a number of drug companies to rethink their strategies. However, it is very clear that in its current form the ADAS Cog underestimates cognitive differences between people and changes over time. To determine if treatments, developed from painstaking years of research, work in expensive studies we need to invest in developing measurement instruments that are fit for purpose. This requires the routine use of different methods. In its current form, the ADAS Cog is not working in people with mild Alzheimer's disease."


Story Source:

The above story is based on materials provided by University of Plymouth. Note: Materials may be edited for content and length.


Journal References:

  1. Jeremy Hobart, Stefan Cano, Holly Posner, Ola Selnes, Yaakov Stern, Ronald Thomas, John Zajicek. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory. Alzheimer's & Dementia, 2012; DOI: 10.1016/j.jalz.2012.08.006
  2. Jeremy Hobart, Stefan Cano, Holly Posner, Ola Selnes, Yaakov Stern, Ronald Thomas, John Zajicek. Putting the Alzheimer’s cognitive test to the test I: Traditional psychometric methods. Alzheimer's & Dementia, 2012; DOI: 10.1016/j.jalz.2012.08.005

Cite This Page:

University of Plymouth. "Flaw in Alzheimer's drug trial test, research suggests." ScienceDaily. ScienceDaily, 16 December 2012. <www.sciencedaily.com/releases/2012/12/121216200803.htm>.
University of Plymouth. (2012, December 16). Flaw in Alzheimer's drug trial test, research suggests. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2012/12/121216200803.htm
University of Plymouth. "Flaw in Alzheimer's drug trial test, research suggests." ScienceDaily. www.sciencedaily.com/releases/2012/12/121216200803.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins